Quidel Corporation (NASDAQ:QDEL) just released its latest quarterly results and things are looking bullish. The…

from Yahoo Finance https://ift.tt/2zwiBiQ

St. Louis Fed President James Bullard joins Yahoo Finance’s Alexis Christofourous, Brian Sozzi and Brian Cheung to discuss why he believes negative interest rates are not a clear remedy for the coronavirus-induced economic crisis in the United States, despite market bets on below-zero rates next year.

from Yahoo Finance https://ift.tt/3fFYXRJ

Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds. One thing they don't realize is that 100% of the passive funds didn't see the coronavirus recession coming, but a lot of hedge funds did. Even we published an article near the end of February and […]

from Yahoo Finance https://ift.tt/2zvsDQX

Quidel Corporation's (NASDAQ: QDEL) development of an antigen test for the novel coronavirus (COVID-19) is a "game changer" in the world's fight against the pandemic, former Food and Drugs Administration commissioner Scott Gottlieb told CBS on Sunday.The test was given emergency use authorization by the FDA late Friday.'Quick And Cost Effective'"I think this kind of technology is a real game changer…it's a very rapid test that could be used in a doctor's office," Gottlieb said at CBS "Face The Nation.""Doctors now have about 40,000 of these Sofia machines already installed in their offices. And you do a simple nasal swab and the test itself scans for the antigens that the virus produces."Gottlieb noted the test is cost-effective and quick to return results. "It'll probably be about five dollars a test and you can get a result within five minutes," he told CBS.According to the former FDA chairman, the test gives accurate results about 85% of the time. Those who don't return coronavirus positive from the test can then see an additional screening through PCR-based tests, which take up to 24 hours to give the results."For those [85%] patients that you could screen out right away, you're getting a very fast result and you can start to take action immediately," he said at the CBS show.CDC Guidelines Will Dictate Adoption If Quidel is able to produce 200,000 testing kits right away, and 1.5 million a week in the coming weeks, as it has suggested, it will "dramatically expand testing capacity in the United States, Gottlieb noted.The physician said that the Center for Disease Control and Prevention and other health authorities would need to come up with proper guidance to ensure that the doctors don't hesitate to test coronavirus patients using the antigen tests."If turning over a positive case in your medical office means that you have to do a deep cleaning and quarantine your nursing staff and close your office, doctors aren't going to be testing," he told CBS.Why It Matters There are more than 1.3 million confirmed COVID-19 cases in the U.S. at press time, and the death toll is nearing 80,000, according to data from Johns Hopkins University. Health experts have warned of a worse second wave, if adequate preventative measures aren't put in place.Multiple vaccines, including those of Moderna Inc. (NASDAQ: MRNA) and Inovio Pharmaceuticals Inc. (NASDAQ: INO), are currently seeing clinical trials.Even a rapidly developed and approved vaccine is unlikely to be available until next year, according to White House Coronavirus Task Force lead member Anthony Fauci and others, making widespread testing the best-available preventative measure to curb the spread of the virus.Price Action Quidel shares closed 3.3% higher at $158.60 on Friday. The shares traded slightly lower in the after-hours session at $158.See more from Benzinga * Trump, Intel, TSMC Plan US 'Self-Sufficiency' In Semiconductors As Coronavirus Gives Supply-Chain Scare * Tesla's China Sales Dropped 64% In April, Even As Wider Market Recovered, CPCA Says * Former Google CEO Eric Schmidt Cut Last Ties With The Company: Report(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

from Yahoo Finance https://ift.tt/2WK69DY

(Bloomberg) — In the equity market, fear of missing out seems to be overshadowing fear of all that’s wrong with the economy. Goldman Sachs Group Inc. says pessimism will soon get the upper hand and send the S&P 500 Index down almost 20% in the next three months.Fiscal and monetary support over the past few weeks of the coronavirus pandemic successfully warded off a financial crisis, but a return to economic normalcy is still a long ways away and investors have gotten ahead of themselves, the bank’s chief U.S. equity strategist, David Kostin, wrote in a report.Financial, economic and political risks darken the outlook for domestic equities, Goldman warns. The bank cites the lack of flattening in the U.S. infection curve outside of New York, what promises to be a lengthy re-start process, a 50% hit to buybacks in 2020 and the risk of higher corporate taxes and de facto consumption taxes if U.S.-China trade tensions bubble up again.“A single catalyst may not spark a pullback, but a number of concerns and risks exist that we believe, and our client discussions confirm, investors are downplaying,” Kostin wrote. Goldman says the S&P 500 will probably drop to 2,400 over the next three months before it rebounds to 3,000 by year end.The index slumped 0.5% Monday to 2,914 as of 9:45 a.m. in New York.Kostin notes that large swaths of the investor community have failed to cash in on the S&P 500’s 31% surge since its trough on March 23. He points out that most mutual funds have underperformed since the bear market low, with long/short and macro hedge funds posting single-digit returns as a group, and investors may face pressure to chase the rally.“The ‘fear of missing out’ best describes the thought process,” Kostin said.But he warns that it’s a risky move. Even with measures of the breadth of the recent rally improving in recent days — potentially signaling more buy-in on the idea the gains will last — Goldman Sachs’ sentiment indicator has barely improved since mid-March.“Skepticism abounds regarding the likelihood the rally will continue,” the strategist writes.Kostin is pessimistic on the outlook for corporate profits, citing frozen growth plans and capital expenditures will drop 27% this year. He points out that the only encouraging driver for earnings is the swelling federal deficit, which in effect acts as substantial support for demand.Caution on equities may also be warranted in the face of stretched valuations — to the extent that anything about 2021’s bottom-line outlook can be discerned.The benchmark U.S. stock gauge trades at 19.5 times the buy side’s estimate of next year’s earnings, Kostin concludes, the highest level since 2002.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

from Yahoo Finance https://ift.tt/3fyfpnj

submitted by /u/The_Woke_OneBench100
[link] [comments]

source https://www.reddit.com/r/StockMarket/comments/gho3ni/lucky_or_smart/

Avianca Holdings (AVH) filed for bankruptcy protection after travel restrictions tied to the coronavirus pandemic brought passenger operations to an almost complete halt since mid-March.The Columbian air carrier said it submitted Chapter 11 proceedings to the U.S. Bankruptcy Court for the Southern District of New York in an effort to preserve jobs, restructure its $7.27 billion in debt and reorganize its business operations. Throughout the restructuring period, it will continue operations, the company said."Avianca is facing the most challenging crisis in our 100-year history as we navigate the effects of the COVID-19 pandemic," said Avianca CEO Anko van der Werff. "Despite the positive results yielded by our 'Avianca 2021' plan, we believe that, in the face of a complete grounding of our passenger fleet and a recovery that will be gradual, entering into this process is a necessary step to address our financial challenges."Avianca's passenger operations have been grounded since mid-March, cutting its consolidated revenue by over 80% and placing significant pressure on its cash reserves. As a result, Latin America’s second-largest carrier implemented employee furloughs, temporary wage reductions, reductions in non-essential capital expenditures and temporary deferred payments on long-term leases.With a fleet of 158 aircraft, Avianca employs more than 21,000 workers throughout Latin America, including more than 14,000 in Colombia, while also working with more than 3,000 vendors.Global shelter-in-place orders to contain the fast spread of the COVID-19 pandemic has resulted in a 90% decline in global passenger traffic and is expected to reduce industry revenues worldwide by $314 billion, according to the International Air Transport Association.Given the impact COVID-19 has had on travel plans, Avianca announced that it will continue to waive change fees and other penalties associated with changes to customers' travel plans for tickets purchased until October 31.At the start of the year, the company had managed to organize an out-of-court reprofiling of its financial debt and lease obligations and raised $375 million in new financing.Shares in Avianca rose 4.1% to $0.88 on Friday trimming the year-to-date plunge to 81%.Last week, five-star analyst Michael Linenberg at Deutsche Bank cut the stock to Sell from Hold and slashed the price target to 50 cents from $2, due to the accelerated COVID-19 impact in Latin America in recent weeks which forced the industry to make large capacity cuts and reduce its network to only fly "essential" routes.Linenberg noted that Latin America was one of the last regions globally to be affected by the coronavirus pandemic, following limited impact for most of the March quarter.Overall Wall Street analysts have a Moderate Sell consensus rating on the stock based on 2 Sells and 1 Hold. The $0.73 average price target implies 17% downside potential for the shares in the coming 12 months. (See Avianca stock analysis on TipRanks). Related News: ON Semiconductor Quarterly Earnings Miss Amid Virus Pandemic, Sees Orders Coming Back Uber Puts Hopes on Food Delivery Momentum After $2.9 Billion Loss Seres Therapeutics Reports Weak Earnings, But Significant Upside Lies Ahead More recent articles from Smarter Analyst: * Debt-Laden Chesapeake Rolls Out $25 Million Incentive Executive Pay Plan * Microsoft to Splash $1.5 Billion on Italy's Cloud Business Transformation * AMC Pops 11% Amid Potential Acquisition Talks by Amazon * Carnival Cruises Enjoys Huge Bookings Surge- Report

from Yahoo Finance https://ift.tt/2Wn2nBx

Sales of Tesla’s (TSLA) Model 3 sedan in China plunged 64% in April vs March, according to new figures from the China Passenger Car Association (CPCA) CNBC reports.Specifically, Tesla sold 3,635 Model 3 cars in April, a significant decrease from the 10,160 vehicles sold in March. This means that Tesla has now sold 19,705 Model 3 cars in China since the beginning of the year.However, while sales fell, demand in China for electric vehicles rose. The country experienced a 9.8% increase in electric car sales from March to April, the CPCA found. The industry association also says that auto demand is now recovering following the coronavirus outbreak.On May 8 Tesla revealed that it secured a 4 billion yuan ($565M) lending line for continued expansion of production at the Gigafactory Shanghai.The plant is currently out of action, reportedly due to supply disruption, with Tesla stating on May 7: “Tesla Shanghai is adjusting to normal production due to test run[s] and maintenance of production lines that were carried out during the recent holidays.” Notably Tesla did not say when production would recommence, simply adding: “All work is being executed according to plan.”Merrill Lynch analyst Ming-Hsun Lee recently upgraded TSLA stock from hold to buy. “In March-April, [Chinese] auto demand at premium segment recovered faster than at mass-market,” Lee explained.However the majority of analysts present a cautious outlook on shares. The Hold consensus is based on 10 recent Hold ratings, 10 Sells and 7 Buys. With shares almost doubling year-to-date, the $627.40 average price target now translates into 23% downside potential from current levels. (See Tesla’s stock analysis on TipRanks)“While we recently raised our Tesla price target to $680, we believe the shares offer a risk/reward skew commensurate with an Equal-Weight rating relative to our sector at this time” Morgan Stanley’s Adam Jonas wrote on May 7.Related News: Uber Puts Hopes on Food Delivery Momentum After $2.9 Billion Loss Southwest Scores $815M With Sale-Leaseback of 20 Boeing Planes GM Ramps Up Coffers With $4 Billion Debt Sale, Plans New $2 Billion Credit Line More recent articles from Smarter Analyst: * Debt-Laden Chesapeake Rolls Out $25 Million Incentive Executive Pay Plan * Microsoft to Splash $1.5 Billion on Italy's Cloud Business Transformation * AMC Pops 11% Amid Potential Acquisition Talks by Amazon * Carnival Cruises Enjoys Huge Bookings Surge- Report

from Yahoo Finance https://ift.tt/2zsnuJH

The U.S. plans to accuse China of attempting to steal information from coronavirus vaccine researchers, Elon Musk says he will move Tesla’s headquarters out of California, and China and South Korea report new clusters of cases. WSJ’s Shelby Holliday has the latest. Photo: Getty Images

from Yahoo Finance https://ift.tt/3boQ23X